Wei Li Lin
Direttore/Membro del Consiglio presso HANDA PHARMACEUTICALS, INC.
Profilo
Wei Li Lin is currently the Chairman of Chuan Fa Biotechnology Co. Ltd., Director-Supervisory Board of Microbio (Shanghai) Co., Ltd., and an Independent Director at Handa Pharmaceuticals, Inc. He previously served as Chairman, President & Spokesman at Fountain Biopharma, Inc. and as a Director at OBI Pharma, Inc. Dr. Lin holds a doctorate degree from Kansas State University.
Posizioni attive di Wei Li Lin
| Società | Posizione | Inizio |
|---|---|---|
| HANDA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 28/09/2017 |
| Microbio (Shanghai) Co., Ltd. | Direttore/Membro del Consiglio | - |
| Chuan Fa Biotechnology Co. Ltd. | Presidente | - |
Precedenti posizioni note di Wei Li Lin
| Società | Posizione | Fine |
|---|---|---|
| OBI PHARMA, INC. | Direttore/Membro del Consiglio | 20/12/2012 |
| FOUNTAIN BIOPHARMA INC | Presidente | - |
Formazione di Wei Li Lin
| Kansas State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| HANDA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Fountain Biopharma, Inc.
 Fountain Biopharma, Inc. Pharmaceuticals: OtherHealth Technology Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
| Microbio (Shanghai) Co., Ltd. | |
| Chuan Fa Biotechnology Co. Ltd. |
- Borsa valori
- Insiders
- Wei Li Lin
